Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00814333 · ClinicalTrials.gov registry record · NA
Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis
A NA study, sponsored by University of Kansas Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT00814333 is a NA study that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 1 participants.
The verdict
NCT00814333, a NA study, was terminated before completion, sponsored by University of Kansas Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Epistaxis is a common problem among people of all ages and backgrounds. However, occasionally epistaxis can be severe enough to require emergency room admission. Among the treatment options for epistaxis, nasal packing is the most common approach. This approach requires a return visit to the clinic for removal of the packing. Additionally, there is a great deal of pain during the insertion and removal of this packing. This study aims to justify the further investigation of thrombin as a potential treatment approach for these patients. Thrombin could provide a treatment approach that reduces pain and eliminates the need for a return visit to the clinic.
Interventions
- DRUG Thrombin-JMI
- DRUG Merocel pack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00814333
The ClinicalTrials.gov registry entry for NCT00814333 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Thrombin-JMI is the first listed.
NCT00814333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00814333 about?
NCT00814333 is a clinical study titled "Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis". Epistaxis is a common problem among people of all ages and backgrounds. However, occasionally epistaxis can be severe enough to require emergency room admission. Among the treatment options for epistaxis, nasal packing is the most common approach. This approach requires a return visit to the clinic ...
What is the current status of trial NCT00814333?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2008-12. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00814333?
The interventions under investigation include: Thrombin-JMI (DRUG), Merocel pack (DRUG).
Who is sponsoring clinical trial NCT00814333?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.